New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 18, 2013
05:34 EDTDB, LIFELife Technologies board issues statement regarding strategic review
The board of Life Technologies (LIFE) has retained Deutsche Bank Securities (DB) and Moelis & Company to assist in its annual strategic review. The board has not decided on any specific course of action.
News For LIFE;DB From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 26, 2015
07:26 EDTDBDeutsche Bank receives government support for restructuring, Bloomberg says
Subscribe for More Information
March 24, 2015
07:21 EDTDBDeutsche Bank weighs three options to improve profits, Bloomberg says
Subscribe for More Information
March 22, 2015
18:14 EDTDBDeutsche Bank revamp to impact retail operations, Reuters says
The planned restructuring by Deutsche Bank will have the most impact on the bank's retail operations, says Reuters. According to sources, the bank's retail operations will "bear the brunt" of the revamp and will most likely be spun off in a stock market listing, added Reuters. Reference Link
17:51 EDTDBLawsky targets Deutsche Bank in Libor probe, FT says
According to people familiar with the matter, New York state's financial services regulator Benjamin Lawsky has joined other regulators investigating Deutsche Bank for manipulation of the Libor benchmark borrowing rate, says the Financial Times. Reference Link
March 20, 2015
07:17 EDTDBDeutsche Bank investors pushing for Postbank sale, Financial Times says
Subscribe for More Information
March 16, 2015
14:08 EDTDBEU regulator says time for fine-tuning, Reuters says
The Basel Committee on Banking Supervision believes the necessary bank regulatory framework is in place though some additional work must be done to finalize leverage ratio and capital floor rules, Reuters reported yesterday, citing statements by secretary-general William Coen at a financial conference in Doha. Coen added, "We're now at the state where we can take a step back and look to see how [the regulations] fit together," cautioning that further analysis must be data-driven but admitting that both banks and regulatory bodies were feeling "regulation fatigue." Publicly traded companies in the space include Banco Santander (SAN), Barclays (BCS), Credit Suisse (CS), Deutsche Bank (DB), HSBC (HSBC), ING Groep (ING), Lloyds Banking (LYG), RBS (RBS) and UBS (UBS). Reference Link
12:43 EDTLIFEOn The Fly: Midday Wrap
Stocks on Wall Street were higher at midday after stimulus talk out of China and a rally in European stock markets lifted the U.S. market at the open. There was little reaction to the dayís domestic economic reports, which included the Empire manufacturing index, industrial production data, and a homebuilder confidence index. The week's big economic news, however, is yet to come, as investors look forward to the conclusion of the Federal Reserve's latest rate setting meeting on Wednesday. ECONOMIC EVENTS: In the U.S., the Empire State manufacturing index dipped to 6.9 in March, versus the consensus forecast for a reading of 8.0. Industrial production edged up 0.1% in February, versus expectations for an increase of 0.2%, and capacity utilization fell to 78.9%, versus the 79.5% consensus forecast. The NAHB homebuilder sentiment index dropped to 53 in March from 55 in February, missing expectation for the index to rise to 56. Oil prices continued to tumble, with U.S. crude dropping to a six-year low below $44 per barrel earlier in the session. In Asia, Chinese Premier Li Keqiang said Sunday that his government has room and the tools to take action should growth falter, without detailing specific remedies the government might pursue. COMPANY NEWS: Valeant (VRX), which not long ago lost out to Actavis (ACT) in the race to buy Allergan (AGN), increased its chances of making sure its latest buyout deal gets done by increasing its takeover offer to Salix Pharmaceuticals (SLXP) by about $1B. Rival bidder Endo Health (ENDP) confirmed that it is withdrawing its cash and stock proposal to acquire Salix after Valeant raised its all-cash bid for Salix to $173 per share from $158 per share. Shares of Valeant and Salix both rose about 2%, while Endo shares gained 2.5% following the announcements. MAJOR MOVERS: Among the notable gainers was Life Time Fitness (LTM), which rose 5% after entering into a definitive agreement to be acquired by private equity firms Leonard Green & Partners and TPG in a transaction valued at more than $4B, or $72.10 per share, in cash. Also higher was Edwards Lifesciences (EW), which rose 8% after the company reported data at this weekend's American College of Cardiology conference. Among the noteworthy losers was iDreamSky (DSKY), which dropped more than 25% after the company lowered its guidance because the launch of a popular casual game was delayed on one of the company distribution platforms and the monetization of another popular casual game was less than expected. Also lower were shares of Enzo Biochem (ENZ), which fell 17% after an appeals court reversed-in-part and vacated-in-part the judgment in Enzoís favor that Life Technologies' (LIFE) Applera Corp. infringed certain Enzo patents. INDEXES: Near midday, the Dow was up 174.81, or 0.98%, to 17,924.12, the Nasdaq was up 39.80, or 0.82%, to 4,911.55, and the S&P 500 was up 20.07, or 0.98%, to 2,073.47.
11:40 EDTLIFEEnzo Biochem to request rehearing of court of appeals decision
Enzo Biochem (ENZ) said, acting upon advice of counsel, that it disagrees with the March 16 split 2-to-1 decision of the Court of Appeals sitting in panel for the Federal Circuit that reverses-in-part and vacates-in-part the judgment in Enzoís favor that Applera Corp., now Life Technologies (LIFE), infringed Enzoís patents covering pioneering technologies relating to compounds used in DNA sequencing systems to read the genetic code, and remands the case to the District Court as to whether the accused product infringes. Counter to the District Courtís construction of the Ď767 patent as allowing for directly-detectable labels on nucleotides and polynucleotides, and counter to the juryís verdict that the patent describes such labelling, the Court of Appeals, held such labelling excluded by claim 1 of that patent. Enzo notes also that the Courtís partial vacatur and reversal of the judgment does not end the case, but remands the case back to the District Court to find whether the accused product infringes. Enzo will request rehearing of that decision, both by the original panel and by the full en banc Court. Enzo believes rehearing is warranted by the panelís failure to give appropriate weight to fact findings, including facts found by the jury, consistent with a broader construction of the patent, as required by the Supreme Courtís recent decision in Teva Pharmaceuticals (TEVA).
09:30 EDTDBConsortium wants to securitize $5.3B of debt from GE Capital, Reuters says
Subscribe for More Information
March 15, 2015
12:41 EDTDBGE sells Australia-New Zealand consumer lending unit to consortium
Subscribe for More Information
March 13, 2015
09:08 EDTDBDeutsche Bank weighs change of U.S. office space, Bloomberg says
Deutsche Bank is weighing whether to leave, stay, or shrink its 1.66M square foot U.S. office at 60 Wall Street, reports Bloomberg, citing two people with knowledge of the matter. The sources said Deutsche informed landlords last year it wants "at least 1M square feet," with one source claiming the 60 Wall St. property would require extensive remodelling if the company stays. The company's lease on the property runs expires in 2022, and the company will consider skyscrapers at the World Trade Center or Hudson Yards areas, said a source. Reference Link

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use